Organised by SHC
Singapore Hepatology Conference 2025
For the Busy Clinician
22 to 23 Aug 2025
8:30 am to 5:00 pm (SGT)
Singapore Hepatology Conference 2025
REGISTRATION FOR The 1st Asian Hepatology Summit includes the Singapore Hepatology Conference 2025.
We are committed to delivering Short, Focused Clinical Updates on all aspects of Hepatology for the Busy Clinician from the World’s leading experts.
REGISTER HERE for The 1st Asian Hepatology Summit organized by SHC
To access SHC e-Resources REGISTER HERE or LOG IN (if you have previously registered for SHC)
Meet Our Experts
List of Speakers will be finalised soon…
Singapore Hepatology Conference 2025 Scientific Programme
in Ballrooms 1 and 2
August, 2026
22
| Programme | Time (SGT) |
|---|---|
| MASLD Session Chairs: Prof. Rinaldi Lesmana & Prof. George Goh |
|
| Welcome Address | 8.20 – 8.30 |
| Debate: Screening at risk patients for NASH – a cost effective strategy in the local context. For: Prof. Chan Wah Kheong View Bio Against: Dr. Yang Wei Lyn View Bio |
8.30 – 9.00 |
| Current treatment options, and monitoring response to treatment Prof. George Goh View Bio |
9.00 – 9.20 |
| MASLD and metabolic health in the context of other liver diseases Dr. Lee Guan Huei View Bio |
9.20 – 9.40 |
| Debunking the myths of dietary intervention in the MASH patient Dr. Mark Cheah View Bio |
9.40 -10.00 |
| Histologic improvement and sustained benefit across hepatic and metabolic biomarkers with pegozafermin therapy: Results from a 48-week multi-center, randomized, double-blind, placebo-controlled Phase 2b trial (ENLIVEN) Dr. Cynthia Hartsfield View Bio |
10.00 – 10.20 |
| Q&A | 10.20 – 10.40 |
| Morning Tea Break | 10.40 – 11.10 |
| Autoimmune Liver Diseases Session Chairs: Dr. Anand Kulkarni & Prof. Rajender Reddy |
|
| PBC: options for UDCA non-responsive patients Prof. Chan Wah Kheong View Bio |
11.10 – 11.30 |
| Difficult to treat Autoimmune Hepatitis Prof. Ajay Duseja View Bio |
11.30 – 11.50 |
| Dilemmas in Management of PSC Prof. Simone Strasser View Bio |
11.50 – 12.10 |
| Complex Case Discussion Dr. Pei Yiying |
12.10 – 12.40 |
| Lunch & Poster Viewing: | |
| a. Liver diseases (other than Viral Hepatitis) | 12.40 – 13.30 |
| b. Viral Hepatitis | 13.30 – 14.10 |
| Advanced Liver Disease and Liver Failure Session Chairs: Prof. Simone Strasser & Dr. Rahul Kumar |
|
| Updates in alcohol associated liver disease Dr. Anand V Kulkarni View Bio |
14.10 – 14.30 |
| When to use and when not to use albumin Dr. Yogesh Chawla View Bio |
14.30 – 14.50 |
| ACLF: From decompensation to acute on chronic liver failure Dr. Rahul Kumar View Bio |
14.50 – 15.10 |
| Recompensation of Decompensated Cirrhosis Prof. Rajender Reddy View Bio |
15.10 – 15.30 |
| Complex Case Discussion Dr. Qiu Tianyu |
15.30 – 16.00 |
| Q&A | 16.00 – 16.30 |
| Close of Day 1 | |
August, 2026
23
| Programme | Time (SGT) |
|---|---|
| HCC Symposium Chairs: Prof. Sakkarin Chirapongsahorn & Dr. Kaina Chen |
|
| Risk stratification in MASLD and viral hepatitis for HCC Prof. Tung Hung Su View Bio |
8.40– 9.00 |
| Novel biomarkers for HCC detection Prof. Amit Singal View Bio |
9.00 – 9.20 |
| Artificial intelligence for HCC management Prof. Amit Singal View Bio |
9.20 – 9.40 |
| Local Regional and Systemic Combination Therapy for HCC Prof. Pierce Chow View Bio |
9.40 – 10.00 |
| Morning Tea Symposium sponsored by Roche – Live in Ballroom 1 & 2 – Live Stream in Ballroom 3 & 4 Innovating Hepatocellular Carcinoma Surveillance with Biomarker-based Algorithm Prof. Henry ChanView Bio |
10.00 – 10.50 |
| Updates in systemic therapy for HCC: Adj. A/Prof. Chee Cheng Ean View Bio |
10.50 – 11:10 |
| Immune checkpoint inhibitors and their complications in people with HCC Dr. Anand V Kulkarni View Bio |
11.10 – 11.30 |
| Complex Case Discussion Assoc. Prof. Dr. Sakkarin Chirapongsathorn View Bio |
11.30 – 12.10 |
| Lunch symposium sponsored by GSK – Live in Ballroom 3 & 4 – Live Stream in Ballroom 1 & 2 Destination functional cure in CHB: What success looks like? |
12.10 – 13.40 |
| a. Welcome and Introduction Prof. Lim Seng Gee View Bio |
12.20 – 12.25 |
| b. Lighting the road ahead: Understanding the burden of CHB & importance of Functional cure Prof. Lim Seng Gee View Bio |
12.25 – 12.40 |
| c. Vital components of Functional Cure – Targeting DNA, reducing HBsAg, and stimulating the immune system Prof. Man Fung Yuen View Bio |
12.40 – 12.55 |
| d. Navigating the path forward: Old and new strategies to achieve Functional Cure Prof. Edward Gane View Bio |
12.55 – 13.10 |
| e. Discussions and Q&A Panel moderated by Prof. Lim Seng Gee View Bio |
13.10 – 13.20 |
| Portal Hypertension Chairs: Dr. Edhel Tripon & Prof. Rajender Reddy |
|
| Debate: Endoscopic Variceal surveillance for Primary Prophylaxis of Variceal Haemorrhage is irrelevant For: Prof. Yogesh Chawla View Bio Against: Prof. Rajender Reddy View Bio |
13.40 – 14.10 |
| Non-cirrhotic portal hypertension: diagnosis, management, and transplant considerations Prof. Ajay Duseja View Bio |
14.10 – 14.30 |
| Harnessing NIT’s for prevention of variceal bleeding Dr. Wong Yu Jun View Bio |
14.30 – 14.50 |
| Novel endoscopic therapies for Variceal Bleeding Prof. Rastilav Kunda View Bio |
14.50 – 15.10 |
| Afternoon tea symposium sponsored by Novo Nordisk – Live in Ballroom 1 & 2 – Live Stream in Ballroom 3 & 4 From Obesity to Liver disease: Redefining treatment paradigms through metabolic intervention Prof. Rahul Kumar View Bio |
15.10 – 16.10 |
| Q&A | 16.10 – 16.30 |
| Complex Case Discussion Dr. Alyssa Sim |
16.30 – 17.00 |
| Close of Singapore Hepatology Conference | 17.00 |
Who Should Attend?
The Singapore Hepatology Conference 2025 programme is designed for busy clinicians, basic and translational researchers, nurse practitioners, pharmacists, from Asia, the Indian Sub-continent, Australia and New Zealand, to exchange information on the latest research, discuss new developments in liver treatment and transplantation, and network with leading experts in the field of hepatology.
Our Attendees Include:
- Hepatology experts.
- Clinical, basic, and translational researchers.
- Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, clinical pathologists, anesthesiologists, and radiologists.
- Primary care physicians.
- Nurse practitioners, registered nurses, physician assistants, pharmacists, and other allied health professionals in hepatology and the disciplines listed above.
- Trainees, and students in the disciplines listed above.
REGISTER HERE for The 1st Asian Hepatology Summit organized by SHC
To access SHC e-Resources REGISTER HERE or LOG IN (if you have previously registered for SHC)